These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 12218132

  • 1. MHC allele-specific molecular features determine peptide/HLA-A2 conformations that are recognized by HLA-A2-restricted T cell receptors.
    Wang Z, Turner R, Baker BM, Biddison WE.
    J Immunol; 2002 Sep 15; 169(6):3146-54. PubMed ID: 12218132
    [Abstract] [Full Text] [Related]

  • 2. Identification of a crucial energetic footprint on the alpha1 helix of human histocompatibility leukocyte antigen (HLA)-A2 that provides functional interactions for recognition by tax peptide/HLA-A2-specific T cell receptors.
    Baker BM, Turner RV, Gagnon SJ, Wiley DC, Biddison WE.
    J Exp Med; 2001 Mar 05; 193(5):551-62. PubMed ID: 11238586
    [Abstract] [Full Text] [Related]

  • 3. Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes.
    Biddison WE, Turner RV, Gagnon SJ, Lev A, Cohen CJ, Reiter Y.
    J Immunol; 2003 Sep 15; 171(6):3064-74. PubMed ID: 12960332
    [Abstract] [Full Text] [Related]

  • 4. MHC recognition by hapten-specific HLA-A2-restricted CD8+ CTL.
    Gagnon SJ, Wang Z, Turner R, Damirjian M, Biddison WE.
    J Immunol; 2003 Sep 01; 171(5):2233-41. PubMed ID: 12928367
    [Abstract] [Full Text] [Related]

  • 5. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles.
    Kawakami Y, Robbins PF, Wang X, Tupesis JP, Parkhurst MR, Kang X, Sakaguchi K, Appella E, Rosenberg SA.
    J Immunol; 1998 Dec 15; 161(12):6985-92. PubMed ID: 9862734
    [Abstract] [Full Text] [Related]

  • 6. Extensive T cell receptor cross-reactivity on structurally diverse haptenated peptides presented by HLA-A2.
    Gagnon SJ, Turner RV, Shiue MG, Damirjian M, Biddison WE.
    Mol Immunol; 2006 Feb 15; 43(4):346-56. PubMed ID: 16310048
    [Abstract] [Full Text] [Related]

  • 7. Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures.
    Hausmann S, Biddison WE, Smith KJ, Ding YH, Garboczi DN, Utz U, Wiley DC, Wucherpfennig KW.
    J Immunol; 1999 May 01; 162(9):5389-97. PubMed ID: 10228016
    [Abstract] [Full Text] [Related]

  • 8. Modification of a tumor-derived peptide at an HLA-A2 anchor residue can alter the conformation of the MHC-peptide complex: probing with TCR-like recombinant antibodies.
    Denkberg G, Klechevsky E, Reiter Y.
    J Immunol; 2002 Oct 15; 169(8):4399-407. PubMed ID: 12370373
    [Abstract] [Full Text] [Related]

  • 9. Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen.
    Denkberg G, Lev A, Eisenbach L, Benhar I, Reiter Y.
    J Immunol; 2003 Sep 01; 171(5):2197-207. PubMed ID: 12928363
    [Abstract] [Full Text] [Related]

  • 10. Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes.
    Schaft N, Willemsen RA, de Vries J, Lankiewicz B, Essers BW, Gratama JW, Figdor CG, Bolhuis RL, Debets R, Adema GJ.
    J Immunol; 2003 Feb 15; 170(4):2186-94. PubMed ID: 12574392
    [Abstract] [Full Text] [Related]

  • 11. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.
    Cohen CJ, Sarig O, Yamano Y, Tomaru U, Jacobson S, Reiter Y.
    J Immunol; 2003 Apr 15; 170(8):4349-61. PubMed ID: 12682272
    [Abstract] [Full Text] [Related]

  • 12. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants.
    Gagnon SJ, Borbulevych OY, Davis-Harrison RL, Baxter TK, Clemens JR, Armstrong KM, Turner RV, Damirjian M, Biddison WE, Baker BM.
    J Mol Biol; 2005 Oct 28; 353(3):556-73. PubMed ID: 16197958
    [Abstract] [Full Text] [Related]

  • 13. Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope.
    Yang X, Chen G, Weng NP, Mariuzza RA.
    J Biol Chem; 2017 Nov 10; 292(45):18618-18627. PubMed ID: 28931605
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The structure and stability of an HLA-A*0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site.
    Khan AR, Baker BM, Ghosh P, Biddison WE, Wiley DC.
    J Immunol; 2000 Jun 15; 164(12):6398-405. PubMed ID: 10843695
    [Abstract] [Full Text] [Related]

  • 19. Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3.
    Yang S, Kittlesen D, Slingluff CL, Vervaert CE, Seigler HF, Darrow TL.
    J Immunol; 2000 Apr 15; 164(8):4204-11. PubMed ID: 10754316
    [Abstract] [Full Text] [Related]

  • 20. Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues.
    Parkhurst MR, Salgaller ML, Southwood S, Robbins PF, Sette A, Rosenberg SA, Kawakami Y.
    J Immunol; 1996 Sep 15; 157(6):2539-48. PubMed ID: 8805655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.